BOSHUTAI

BOSHUTAI is a brand name for Acarbose tablets, a pharmaceutical drug developed by Uni-Bio Science Group. It is indicated for the treatment of impaired glucose tolerance and type 2 diabetes, primarily to decrease post-prandial glucose levels. Acarbose, the active ingredient, is an alpha-glucosidase inhibitor that works by delaying the digestion and absorption of carbohydrates in the small intestine, thereby reducing post-meal blood glucose spikes. BOSHUTAI (Acarbose Tablets) is listed as a first-line therapeutic drug in the China Diabetes Prevention and Therapy Guide 2017 and is included in the National Essential Medicine List and National Basic Medical Insurance in China.

Brand names

BOSHUTAI